283 related articles for article (PubMed ID: 26041837)
21. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
Zuo H; Yang Q
J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
[TBL] [Abstract][Full Text] [Related]
22. P-cadherin and vimentin are useful basal markers in breast cancers.
Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
[TBL] [Abstract][Full Text] [Related]
23. Basal biomarkers nestin and INPP4b identify intrinsic subtypes accurately in breast cancers that are weakly positive for oestrogen receptor.
Asleh-Aburaya K; Sheffield BS; Kos Z; Won JR; Wang XQ; Gao D; Wolber R; Gilks CB; Bernard PS; Chia SK; Nielsen TO
Histopathology; 2017 Jan; 70(2):185-194. PubMed ID: 27402148
[TBL] [Abstract][Full Text] [Related]
24. Low expression of PinX1 is associated with malignant behavior in basal-like breast cancer.
Feng YZ; Zhang QY; Fu MT; Zhang ZF; Wei M; Zhou JY; Shi R
Oncol Rep; 2017 Jul; 38(1):109-119. PubMed ID: 28586040
[TBL] [Abstract][Full Text] [Related]
25. Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.
Mullins M; Perreard L; Quackenbush JF; Gauthier N; Bayer S; Ellis M; Parker J; Perou CM; Szabo A; Bernard PS
Clin Chem; 2007 Jul; 53(7):1273-9. PubMed ID: 17525107
[TBL] [Abstract][Full Text] [Related]
26. Expression level of miR-93 in formalin-fixed paraffin-embedded tissues of breast cancer patients.
Deng ZQ; Qian J; Liu FQ; Lin J; Shao R; Yin JY; Tang Q; Zhang M; He L
Genet Test Mol Biomarkers; 2014 May; 18(5):366-70. PubMed ID: 24606013
[TBL] [Abstract][Full Text] [Related]
27. Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization.
Annaratone L; Simonetti M; Wernersson E; Marchiò C; Garnerone S; Scalzo MS; Bienko M; Chiarle R; Sapino A; Crosetto N
Oncotarget; 2017 Mar; 8(12):18680-18698. PubMed ID: 28423635
[TBL] [Abstract][Full Text] [Related]
28. Plasma Autoantibodies Associated with Basal-like Breast Cancers.
Wang J; Figueroa JD; Wallstrom G; Barker K; Park JG; Demirkan G; Lissowska J; Anderson KS; Qiu J; LaBaer J
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1332-40. PubMed ID: 26070530
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of HER2 Gene Status in Breast Cancer Samples with Indeterminate Fluorescence in Situ Hybridization by Quantitative Real-Time PCR.
Koudelakova V; Berkovcova J; Trojanec R; Vrbkova J; Radova L; Ehrmann J; Kolar Z; Melichar B; Hajduch M
J Mol Diagn; 2015 Jul; 17(4):446-55. PubMed ID: 25956448
[TBL] [Abstract][Full Text] [Related]
30. Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples.
Kalmár A; Wichmann B; Galamb O; Spisák S; Tóth K; Leiszter K; Nielsen BS; Barták BK; Tulassay Z; Molnár B
Diagn Pathol; 2015 Jul; 10():126. PubMed ID: 26208990
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
[TBL] [Abstract][Full Text] [Related]
32. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Wallden B; Storhoff J; Nielsen T; Dowidar N; Schaper C; Ferree S; Liu S; Leung S; Geiss G; Snider J; Vickery T; Davies SR; Mardis ER; Gnant M; Sestak I; Ellis MJ; Perou CM; Bernard PS; Parker JS
BMC Med Genomics; 2015 Aug; 8():54. PubMed ID: 26297356
[TBL] [Abstract][Full Text] [Related]
33. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
34. Divisional role of quantitative HER2 testing in breast cancer.
Yamamoto-Ibusuki M; Yamamoto Y; Fu P; Yamamoto S; Fujiwara S; Honda Y; Iyama K; Iwase H
Breast Cancer; 2015 Mar; 22(2):161-71. PubMed ID: 23604955
[TBL] [Abstract][Full Text] [Related]
35. FOXC1.
Li M; Lv H; Zhong S; Zhou S; Lu H; Yang W
Arch Pathol Lab Med; 2022 Aug; 146(8):994-1003. PubMed ID: 34784418
[TBL] [Abstract][Full Text] [Related]
36. Dysregulated expression of Slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer.
Liu T; Zhang X; Shang M; Zhang Y; Xia B; Niu M; Liu Y; Pang D
J Surg Oncol; 2013 Feb; 107(2):188-94. PubMed ID: 22886823
[TBL] [Abstract][Full Text] [Related]
37. FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.
Han B; Qu Y; Jin Y; Yu Y; Deng N; Wawrowsky K; Zhang X; Li N; Bose S; Wang Q; Sakkiah S; Abrol R; Jensen TW; Berman BP; Tanaka H; Johnson J; Gao B; Hao J; Liu Z; Buttyan R; Ray PS; Hung MC; Giuliano AE; Cui X
Cell Rep; 2015 Nov; 13(5):1046-58. PubMed ID: 26565916
[TBL] [Abstract][Full Text] [Related]
38. Forkhead box C1 promoter upstream transcript, a novel long non-coding RNA, regulates proliferation and migration in basal-like breast cancer.
Liu J; Shen L; Yao J; Li Y; Wang Y; Chen H; Geng P
Mol Med Rep; 2015 Apr; 11(4):3155-9. PubMed ID: 25516208
[TBL] [Abstract][Full Text] [Related]
39. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
Gruber K; Horn H; Kalla J; Fritz P; Rosenwald A; Kohlhäufl M; Friedel G; Schwab M; Ott G; Kalla C
J Thorac Oncol; 2014 Mar; 9(3):307-15. PubMed ID: 24495999
[TBL] [Abstract][Full Text] [Related]
40. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer.
Kashiwagi S; Yashiro M; Takashima T; Aomatsu N; Kawajiri H; Ogawa Y; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
Br J Surg; 2013 Mar; 100(4):490-6. PubMed ID: 23319435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]